Operating cash flow swung from $562.5M in 2026Q1 to negative $87.5M in 2026Q3 as working capital outflows of $146.9M outweighed $33.4M of net income, leaving free cash flow margin at -13.6%.
AMN Healthcare Services, Inc. (AMN) cash flow statement — 26-year operating, investing & financing cash flows
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 |
|---|
| Cash from Operations | 360.57M | 269.46M | 320.42M | 372.17M | 653.73M | 305.36M | 256.83M | 224.86M | 226.99M | 115.26M | 131.85M | 57.05M | 27.68M | 58.64M | 60.51M | 19.31M | 8.09M | 98.73M | 63.69M | 79.64M | 54.54M | 44.09M | 39.04M | 65.14M | 56.85M | 1.68M | -1.59M |
| Operating CF Margin % | - | 9.87% | 10.74% | 9.82% | 12.47% | 7.66% | 10.73% | 10.12% | 10.63% | 5.8% | 6.93% | 3.9% | 2.67% | 5.8% | 6.34% | 2.18% | 1.17% | 12.99% | 5.23% | 6.84% | 5.04% | 6.25% | 6.21% | 9.12% | 7.33% | 0.32% | -0.69% |
| Operating CF Growth % | -317.24% | -15.9% | -13.9% | -43.07% | 114.09% | 18.9% | 14.21% | -0.94% | 96.94% | -12.58% | 131.1% | 106.13% | -52.8% | -3.1% | 213.34% | 138.74% | -91.81% | 55.01% | -20.02% | 46.02% | 23.7% | 12.94% | -40.08% | 14.59% | 3286.12% | 205.86% | - |
| Net Income | 109.02M | -95.7M | -146.98M | 210.68M | 444.05M | 327.39M | 70.67M | 113.99M | 141.74M | 132.56M | 105.84M | 81.89M | 33.22M | 32.93M | 15.95M | -26.27M | -51.99M | -122.18M | 34.36M | 36.53M | 35.09M | 22.23M | 17.35M | 37.79M | 52.36M | -4.39M | -5.2M |
| Depreciation & Amortization | 138.81M | 156.6M | 173.78M | 160.93M | 137.11M | 103.7M | 94.19M | 58.52M | 41.24M | 32.28M | 29.62M | 20.95M | 15.99M | 13.54M | 14.15M | 16.42M | 15.08M | 13.81M | 14.44M | 11.67M | 10.32M | 6.18M | 5.84M | 4.82M | 3.84M | 7.71M | 3.3M |
| Stock-Based Compensation | 34.02M | 30.68M | 23.32M | 18.02M | 30.07M | 25.22M | 20.46M | 16.24M | 10.81M | 10.24M | 11.4M | 10.28M | 7.16M | 6.13M | 6.22M | 7.13M | 8.28M | 8.71M | 9.32M | 8.39M | 6.8M | 142K | 16.1K | 874K | 31.88M | 31.88M | 0 |
| Deferred Taxes | -18.36M | -19.55M | 0 | -12.93M | -24.61M | -16.29M | -21.63M | 913K | -667K | 5.61M | -9.42M | 12.68M | 11.78M | 3.03M | 6.95M | -1.79M | -10.71M | -51.72M | -3.37M | 1.14M | 18.08M | 19.02M | 4.09M | 6.04M | 7.29M | -8.65M | -9.73M |
| Other Non-Cash Items | 8.07M | 96.39M | 184.39M | 45.6M | 67.68M | 8.84M | 26.01M | 16.22M | 2.25M | 12.85M | 11.12M | 1.58M | 7.14M | 1.84M | 19.51M | 47.67M | 57.98M | 185.6M | 1.76M | 2.13M | -2.74M | 4.48M | 2.44M | 1.6M | -27.58M | 14.28M | 27.02M |
| Working Capital Changes | 89.01M | 101.03M | 85.91M | -50.13M | -558K | -143.49M | 67.13M | 18.98M | 31.61M | -78.27M | -16.7M | -70.33M | -47.61M | 1.16M | -2.27M | -23.84M | -10.56M | 64.51M | 7.18M | 19.77M | -13.01M | -7.96M | 9.32M | 14.02M | -10.94M | -39.16M | -16.98M |
| Change in Receivables | -11M | 74.75M | 219.44M | 224.85M | 20.04M | -585.27M | -8.61M | 5.71M | -10.58M | -10.64M | -57.16M | -98.02M | -52.13M | -8.45M | 1.39M | -29.02M | -15.3M | 88.73M | 10.41M | 5.53M | -40.6M | -474K | 0 | -30.15M | -39.48M | -39.48M | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | -256.12M | -5.56M | -1.93M | 14.56M | -32.63M | -3.34M | -7.34M | -4M | 4.33M | -12.29M | 5.6M | 1.16M | 0 | -6.91M | 8.57M | 23.83M | -106.36M | 0 | -36.48M | -111.42M | -118.81M | 0 |
| Change in Payables | 27.8M | -20.57M | 0 | -183.52M | 0 | 256.12M | 5.56M | 1.93M | 17.15M | -7.86M | 17.7M | 29.61M | 6.13M | 4.34M | 2.83M | 3.66M | 8.94M | 0 | 1.94M | 1.72M | 1.18M | -1.2M | 0 | 3.66M | 2.65M | 2.65M | 0 |
| Cash from Investing | -46.62M | 4.3M | -79.94M | -412.49M | -170.71M | -107.4M | -538.17M | -291.82M | -279.34M | -33.45M | -257.36M | -116.83M | -28.23M | -47.9M | 2.96M | -1.98M | -6.85M | -29.25M | -48.25M | -14.63M | -45.68M | -115.33M | -5.06M | -14.01M | 1.45M | -33.78M | -94.14M |
| Capital Expenditures | -34.04M | -35.63M | -80.89M | -105.39M | -75.83M | -53.66M | -39.1M | -36.46M | -36.39M | -26.53M | -21.96M | -27.01M | -19.13M | -9.05M | -5.47M | -4.65M | -4.17M | -3.79M | -8.79M | -9.15M | -9.71M | -3.82M | -5.06M | -13.01M | -4.33M | -4.5M | -2.36M |
| CapEx % of Revenue | 0.97% | 1.3% | 2.71% | 2.78% | 1.45% | 1.35% | 1.63% | 1.64% | 1.7% | 1.33% | 1.15% | 1.85% | 1.85% | 0.89% | 0.57% | 0.52% | 0.6% | 0.5% | 0.72% | 0.79% | 0.9% | 0.54% | 0.8% | 1.82% | 0.56% | 0.87% | 1.02% |
| Acquisitions | -3.03M | 65.28M | 0 | -292.18M | -69.5M | -41.26M | -476.43M | -247.91M | -217.36M | -1.5M | -218.34M | -85.07M | -14.47M | -39.5M | 0 | 0 | -3.23M | 0 | -30.95M | -5.48M | -35.96M | -111.51M | 0 | -9.53M | -9.53M | -12.97M | -91.79M |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 1K | 22K | -6.76M | -24.9M | -26.61M | -8.99M | -7.66M | -13.29M | -10.67M | -8.62M | -5.91M | -3M | 10.38M | 647K | 8.43M | 2.67M | 553K | -25.46M | -8.5M | 0 | 0 | 0 | 0 | -1M | 15.31M | -19.09M | 8K |
| Cash from Financing | -121.47M | -295.89M | -259.45M | 10.73M | -591.87M | -34.9M | 211.49M | 136.6M | 37.51M | -77.19M | 126.29M | 56.2M | -2.1M | -783K | -61.68M | -15.3M | -26.45M | -53.81M | -22.33M | -50.92M | -23.54M | 86.52M | -34.75M | -86.47M | -33.82M | 47.21M | 95.77M |
| Debt Issued (Net) | -100M | -285M | -250M | 456.12M | 0 | -21.88M | 240.54M | 180M | 120M | -44.06M | 149.68M | 57M | 2.23M | -681K | -53.73M | -12.5M | -21.86M | -53.65M | 2.04M | -37.92M | -21.81M | 89.11M | -36.42M | 137.37M | -662K | -128.87M | 45.18M |
| Equity Issued (Net) | -13.18M | -2.09M | 0 | -424.74M | -576.77M | -2.69M | -6.93M | -18.7M | -67.01M | -20.16M | -13.26M | 0 | 0 | 0 | 530K | 0 | 0 | 0 | -28.45M | -16.29M | -10.58M | 2.32M | 1.93M | -219.21M | -33.06M | 177.34M | 52M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -13.18M | -2.09M | 0 | -424.74M | -576.77M | -2.69M | -6.93M | -18.7M | -67.01M | -20.16M | -13.26M | -11.91M | -4.45M | -2.67M | -1.07M | 0 | 0 | 0 | -28.45M | -18.51M | -37.53M | 0 | -110K | -219.26M | -35.16M | 0 | 0 |
| Other Financing | -8.29M | -8.8M | -9.45M | -20.65M | -15.1M | -10.33M | -22.13M | -24.7M | -15.48M | -12.97M | -10.13M | -796K | -4.33M | 262K | -8.48M | -2.8M | -4.59M | -156K | 4.07M | 3.29M | 8.86M | -4.9M | -258K | -4.63M | -101K | -1.26M | -1.41M |
| Net Change in Cash | 198.04M | -22.13M | -18.97M | -46.76M | -108.84M | 162.72M | -69.97M | 69.64M | -14.57M | 4.53M | 1.05M | -3.5M | -2.51M | 9.9M | 1.72M | 2.08M | -25.17M | 15.74M | -7.18M | 14.07M | -14.69M | 15.2M | -779K | -35.45M | 24.48M | 15.11M | 43K |
| Free Cash Flow | 327.03M | 233.83M | 239.53M | 268.48M | 572.81M | 251.69M | 217.72M | 188.4M | 190.61M | 88.73M | 109.89M | 30.04M | 8.54M | 49.59M | 55.04M | 14.66M | 3.92M | 94.94M | 54.9M | 70.48M | 44.82M | 40.27M | 33.98M | 52.13M | 52.52M | -2.82M | -3.94M |
| FCF Margin % | 9.3% | 8.56% | 8.03% | 7.09% | 10.92% | 6.32% | 9.1% | 8.48% | 8.92% | 4.46% | 5.78% | 2.05% | 0.82% | 4.9% | 5.77% | 1.65% | 0.57% | 12.5% | 4.51% | 6.06% | 4.14% | 5.71% | 5.4% | 7.3% | 6.77% | -0.54% | -1.71% |
| FCF Growth % | 46.79% | -2.38% | -10.78% | -53.13% | 127.58% | 15.6% | 15.56% | -1.16% | 114.81% | -19.26% | 265.79% | 251.63% | -82.77% | -9.9% | 275.34% | 273.99% | -95.87% | 72.94% | -22.11% | 57.25% | 11.3% | 18.53% | -34.83% | -0.75% | 1963.91% | 28.55% | - |
| FCF per Share | 8.14 | 6.07 | 6.27 | 6.82 | 12.77 | 5.24 | 4.57 | 3.96 | 3.92 | 1.80 | 2.23 | 0.62 | 0.18 | 1.04 | 1.18 | 0.32 | 0.11 | 2.91 | 1.62 | 2.02 | 1.30 | 1.25 | 1.08 | 1.31 | 1.12 | -0.09 | -0.18 |
| FCF Conversion (FCF/Net Income) | 3.00x | -2.82x | -2.18x | 1.77x | 1.47x | 0.93x | 3.63x | 1.97x | 1.60x | 0.87x | 1.25x | 0.70x | 0.83x | 1.78x | 3.53x | -0.74x | -0.16x | -0.81x | 1.85x | 2.18x | 1.55x | 1.98x | 2.25x | 1.72x | 1.09x | -0.38x | 0.31x |
| Interest Paid | 48.96M | 45.11M | 61.03M | 48.1M | 37.52M | 38.09M | 22.65M | 23.73M | 21.28M | 17.94M | 8.06M | -5.81M | 4.6M | 7.41M | 13.7M | 19.67M | 16.43M | 7.39M | 9.6M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 65.8M | 7.85M | 28.15M | 78.26M | 213.81M | 106.38M | 46.26M | 37.75M | 30.59M | 73.75M | 73.37M | -33.13M | 17.88M | 18.86M | 1.86M | 388K | 84K | 5.61M | 32.95M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying AMN stock.
AMN Healthcare Services, Inc. (AMN) generated $269.5M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
AMN Healthcare Services, Inc. (AMN) generated $233.8M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.
AMN Healthcare Services, Inc. (AMN) spent $35.6M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.
In 2025, AMN Healthcare Services, Inc. (AMN) spent $2.1M on share repurchases. This shows the company's commitment to returning capital to its equity investors.
Key Metrics
Top Statement Risk
Volatile working capital swings
Metrics are mathematically derived from official filings.
Operating Cash Flow Diverges From Earnings
According to the reported quarterly figures, AMN's operating cash flow swung from $562.5M in 2026Q1 to negative $189.9M in 2026Q2 while net income remained positive at $21.2M, a gap that suggests working capital timing rather than earnings power is driving cash generation.
The OCF-to-net-income ratio has been erratic, ranging from roughly -9x to +9x across recent quarters, which makes the ratio itself uninformative and points instead to large swings in receivables and payables. Such dispersion suggests reported earnings are not translating into cash on a consistent basis. Investors should monitor whether the 2026Q1 inflow reverses in subsequent periods, as it may reflect collection of receivables built up earlier rather than durable conversion.
Working Capital Dominates Cash Movements
Based on AMN's reported figures, working capital changes of negative $146.9M in 2026Q3 and negative $215.1M in 2026Q2 outweighed net income of $33.4M and $21.2M, indicating that receivables management is the primary determinant of near-term cash flow.
The magnitude of working capital swings relative to net income suggests that collection timing, and potentially hospital payment delays, are materially influencing reported cash. A sustained build in receivables during a period of declining revenue may indicate customers are stretching payments, which warrants further investigation via the allowance for doubtful accounts and DSO trends. The reversal in 2026Q1 suggests this dynamic is cyclical rather than structural, but the consistency of outflows in recent quarters is a concern.
Free Cash Flow Negative Across Recent Quarters
As reported in financial statements, AMN's free cash flow was negative $97.3M in 2026Q3 and negative $198.5M in 2026Q2, with FCF margins of negative 13.6% and negative 29.5%, respectively, following a positive $555.2M quarter in 2026Q1.
The sharp reversal from a strong Q1 inflow to two consecutive large outflows suggests FCF is highly sensitive to working capital rather than underlying operating profitability. Capital expenditure remains modest at roughly 0.5% to 1.5% of revenue in recent quarters, so the FCF deterioration is not driven by investment spending. Investors should view the Q1 2026 result with caution, as it may not represent a sustainable run rate.
Light Capital Intensity Limits Investment Drag
Based on EDBL-style reported figures, AMN's capital expenditures have stayed between 0.5% and 3.7% of revenue over the past ten quarters, with recent quarters near 1.3%, indicating a low-capital-intensity staffing model.
CapEx running below depreciation of roughly $32M to $44M per quarter suggests the company is not reinvesting heavily in its asset base, which is consistent with a services business where technology spend may be partially expensed. The decline in CapEx from 3.7% of revenue in 2024Q2 may reflect cost discipline during the revenue contraction. Whether this underinvestment compromises the VMS and technology platforms over time warrants monitoring.
Cumulative Cash Reality Versus Reported Profit
According to reported quarterly figures, cumulative net income across the sampled ten quarters is negative when including the large 2024Q4 and 2025Q2 losses, while cumulative operating cash flow is substantially positive, a divergence that depends heavily on the timing of the 2026Q1 inflow.
Over the sampled window, cash generation has exceeded reported earnings in aggregate, which may reflect non-cash charges such as amortization and impairments embedded in the net losses. The divergence is not unambiguous, however, because the strong 2026Q1 inflow carries much of the weight in that comparison. Investors should treat the cumulative picture as dependent on whether the working capital release proves durable.
What the Cash Flow Statement May Obscure
Based on reported figures, AMN's stock-based compensation of $8.5M to $9.9M per quarter and amortization embedded in D&A of roughly $32M to $44M per quarter may flatter operating cash flow relative to the economic cost of the business, warranting scrutiny of underlying cash quality.
Stock-based compensation is a non-cash add-back that reduces reported net income impact but represents a real economic cost to shareholders through dilution, so OCF may overstate sustainable cash generation to a degree. Large acquisition-related intangibles inflate D&A, and the gap between D&A and CapEx suggests reinvestment may lag the amortization base over time. The 2026Q1 inflow may also reflect collection of receivables that management could have accelerated, so investors should verify whether the release is sustainable before extrapolating it.